Siete, Baby Girl .
HRN: 26-37-74 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/20/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
12/20/2024
12/27/2024
IV
40 Mg
Q 24
PSNB
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes